ERVW-1 and myeloid sarcoma: Of particular interest in comparing patients with MS + CIS versus SC + RIS is the significant difference between HERV H3 Env epitopes on the nonclassical monocyte population, making it the only surface marker analyzed that is able to distinguish between these patient groups (Figures 2 and 3).